Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
sharewise is moving On the weekend of 22/23 August the new sharewise becomes the main site. Have a look now and tell us what you miss. Go to the new sharewise What changes
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Corvus Pharmaceuticals Inc buy DomRuinart

Corvus Pharmaceuticals Inc
Start price
€2.18
31.05.21 / 50%
Target price
€4.00
31.05.22
Performance (%)
4.59%
End price
€2.28
14.06.21
Summary
This prediction ended on 14.06.21 with a price of €2.28. With a performance of 4.59%, the BUY prediction by DomRuinart for Corvus Pharmaceuticals Inc closed with a slight gain. DomRuinart has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y 3y
Corvus Pharmaceuticals Inc 0.324% 0.324% 179.571% 584.254%
iShares Core DAX® -1,06 % 5,01 % 6,60 % 64,71 %
iShares Nasdaq 100 -2,39 % 0,86 % 25,79 % 88,24 %
iShares Nikkei 225® -4,36 % 1,21 % 41,31 % 79,31 %
iShares S&P 500 -1,78 % 1,39 % 21,04 % 69,60 %

According to DomRuinart what are the pros and cons of Corvus Pharmaceuticals Inc for the foreseeable future?

Pros
Could be worthwhile Investment >10% per year
Cons

Comments by DomRuinart for this prediction

In the thread Corvus Pharmaceuticals Inc diskutieren
Prediction Buy
Perf. (%) 4.59%
Target price 4.000
Change
Ends at 31.05.22

Buy mit Kursziel 4,0

DomRuinart 
0
Report Share
31.05.21
In the thread Trading Corvus Pharmaceuticals Inc
Prediction Buy
Perf. (%) 4.59%
Target price 4.000
Change
Ends at 31.05.22

Buy beendet

DomRuinart 
0
Report Share
14.06.21